Accuray

ARAY

Market cap $204M

5D Clinics and Joint Venture Partner Icon Group Make Strides in Delivering on Commitment to Increasing Access to World-class Radiation Treatments for More Communities Across Australia. MADISON, Wis.

MADISON, Wis. , Sept. 30, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) and the University of Wisconsin School of Medicine and Public Health (UW SMPH) announced today the signing of a memorandum of understanding (MOU) to advance online adaptive radiotherapy (OART) on the Accuray helical radiation treatment delivery platform.

Accuray Incorporated (NASDAQ:ARAY ) Shareholder/Analyst Call September 29, 2025 4:30 PM EDT Company Participants Suzanne Winter - President, CEO & Director Mu Lee - Senior Vice President of Research & Product Development Seth Blacksburg - Senior VP & Chief Medical Officer Conference Call Participants Shalom Kalnicki Jonathan Haas Giuseppe Sasso John Kresl Presentation Suzanne Winter President, CEO & Director Good afternoon, everyone, and welcome to Accuray's Analyst briefing. We're coming to you from the ASTRO conference in San Francisco for 2025.

New Solution Provides an Unprecedented Set of Tools, Empowering Clinical Teams With Choice and Flexibility to Deliver Adaptive Care—Tailoring Radiotherapy to Each Patient's Unique Needs MADISON, Wis. , Sept. 26, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the company is advancing its legacy of leadership in adaptive radiotherapy with the introduction of the Accuray Stellar™* Solution.

ARAY sees strong order momentum, APAC growth and CyberKnife demand, but soft product sales and regional headwinds cloud near-term gains.

Event Will Feature Global KOLs Sharing Their Perspectives on the Role of Adaptive Radiotherapy in Radiation Medicine MADISON, Wis. , Sept. 11, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the company will host a discussion with analysts and investors on Monday, September 29, 2025, in conjunction with the American Society of Radiation Oncology (ASTRO) Annual Meeting in San Francisco, California.

ARAY stock down after Q4 earnings miss estimates, with product sales hit by tariffs and regional demand softness.

Accuray Incorporated (NASDAQ:ARAY ) Q4 2025 Earnings Conference Call August 13, 2025 4:30 PM ET Company Participants Ali Pervaiz - Senior VP & CFO Suzanne Winter - President, CEO & Director Conference Call Participants Jason Hart Wittes - ROTH Capital Partners, LLC, Research Division Marie Yoko Thibault - BTIG, LLC, Research Division Operator Welcome to the Accuray Fourth Quarter Fiscal 2025 Financial Results Conference Call. [Operator Instructions] Please note, this event is being recorded.

Accuray (ARAY) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of $0.03. This compares to earnings of $0.03 per share a year ago.

Strong Service Growth; Debt Refinancing Complete; Company Issues FY26 Guidance MADISON, Wis., Aug. 13, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter and fiscal 2025, ended June 30, 2025.